Anne‐Brita Knapskog

2.0k total citations
67 papers, 1.2k citations indexed

About

Anne‐Brita Knapskog is a scholar working on Psychiatry and Mental health, Physiology and Neurology. According to data from OpenAlex, Anne‐Brita Knapskog has authored 67 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Psychiatry and Mental health, 25 papers in Physiology and 14 papers in Neurology. Recurrent topics in Anne‐Brita Knapskog's work include Dementia and Cognitive Impairment Research (47 papers), Alzheimer's disease research and treatments (21 papers) and Neuroinflammation and Neurodegeneration Mechanisms (11 papers). Anne‐Brita Knapskog is often cited by papers focused on Dementia and Cognitive Impairment Research (47 papers), Alzheimer's disease research and treatments (21 papers) and Neuroinflammation and Neurodegeneration Mechanisms (11 papers). Anne‐Brita Knapskog collaborates with scholars based in Norway, Sweden and United Kingdom. Anne‐Brita Knapskog's co-authors include Knut Engedal, Maria Lage Barca, Ingvild Saltvedt, Geir Selbæk, Karin Persson, Rannveig Sakshaug Eldholm, Trine Holt Edwin, Ragnhild Munthe‐Kaas, Anne Brækhus and Hanne Ellekjær and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Stroke.

In The Last Decade

Anne‐Brita Knapskog

66 papers receiving 1.2k citations

Peers

Anne‐Brita Knapskog
Anne‐Brita Knapskog
Citations per year, relative to Anne‐Brita Knapskog Anne‐Brita Knapskog (= 1×) peers Kristian Steen Frederiksen

Countries citing papers authored by Anne‐Brita Knapskog

Since Specialization
Citations

This map shows the geographic impact of Anne‐Brita Knapskog's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne‐Brita Knapskog with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne‐Brita Knapskog more than expected).

Fields of papers citing papers by Anne‐Brita Knapskog

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne‐Brita Knapskog. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne‐Brita Knapskog. The network helps show where Anne‐Brita Knapskog may publish in the future.

Co-authorship network of co-authors of Anne‐Brita Knapskog

This figure shows the co-authorship network connecting the top 25 collaborators of Anne‐Brita Knapskog. A scholar is included among the top collaborators of Anne‐Brita Knapskog based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne‐Brita Knapskog. Anne‐Brita Knapskog is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Persson, Karin, Maria Lage Barca, Trine Holt Edwin, et al.. (2024). Regional MRI volumetry using NeuroQuant versus visual rating scales in patients with cognitive impairment and dementia. Brain and Behavior. 14(2). e3397–e3397. 3 indexed citations
2.
Aam, Stina, Stian Lydersen, Per Magne Ueland, et al.. (2024). Neopterin, kynurenine metabolites, and indexes related to vitamin B6 are associated with post-stroke cognitive impairment: The Nor-COAST study. Brain Behavior and Immunity. 118. 167–177. 3 indexed citations
3.
Edwin, Trine Holt, Ingvild Saltvedt, Rannveig Sakshaug Eldholm, et al.. (2023). Sex-specific associations of matrix metalloproteinases in Alzheimer’s disease. Biology of Sex Differences. 14(1). 35–35. 9 indexed citations
4.
Aam, Stina, Torunn Askim, Mona K. Beyer, et al.. (2023). Plasma Inflammatory Biomarkers Are Associated With Poststroke Cognitive Impairment: The Nor-COAST Study. Stroke. 54(5). 1303–1311. 20 indexed citations
5.
Persson, Karin, Esten H. Leonardsen, Trine Holt Edwin, et al.. (2023). Diagnostic accuracy of brain age prediction in a memory clinic population and comparison with clinically available volumetric measures. Scientific Reports. 13(1). 14957–14957. 3 indexed citations
6.
Henjum, Kristi, Leiv Otto Watne, Kristin Godang, et al.. (2022). Cerebrospinal fluid catecholamines in Alzheimer’s disease patients with and without biological disease. Translational Psychiatry. 12(1). 151–151. 36 indexed citations
7.
Persson, Karin, Trine Holt Edwin, Anne‐Brita Knapskog, et al.. (2022). Hippocampal Atrophy Subtypes of Alzheimer’s Disease Using Automatic MRI in a Memory Clinic Cohort: Clinical Implications. Dementia and Geriatric Cognitive Disorders. 51(1). 80–89. 5 indexed citations
8.
Watne, Leiv Otto, C. Pollmann, Bjørn Erik Neerland, et al.. (2022). Cerebrospinal fluid quinolinic acid is strongly associated with delirium and mortality in hip-fracture patients. Journal of Clinical Investigation. 133(2). 21 indexed citations
9.
Aass, Hans Christian D., Ann Tiiman, Trine Holt Edwin, et al.. (2021). Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer’s disease. Translational Neurodegeneration. 10(1). 18–18. 7 indexed citations
10.
Tiiman, Ann, Trine Holt Edwin, Lars Terenius, et al.. (2021). Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer’s Disease. Frontiers in Aging Neuroscience. 12. 608628–608628. 3 indexed citations
12.
Løhaugen, Gro C., Jon Skranes, Anne‐Brita Knapskog, et al.. (2021). Working Memory Training in Amnestic and Non-amnestic Patients With Mild Cognitive Impairment: Preliminary Findings From Genotype Variants on Training Effects. Frontiers in Aging Neuroscience. 13. 624253–624253. 7 indexed citations
13.
Spigset, Olav, Torunn Askim, Mona K. Beyer, et al.. (2020). Vascular risk factor control and adherence to secondary preventive medication after ischaemic stroke. Journal of Internal Medicine. 289(3). 355–368. 15 indexed citations
14.
Aam, Stina, Ragnhild Munthe‐Kaas, Stian Lydersen, et al.. (2020). Post-stroke Cognitive Impairment—Impact of Follow-Up Time and Stroke Subtype on Severity and Cognitive Profile: The Nor-COAST Study. Frontiers in Neurology. 11. 699–699. 69 indexed citations
15.
Edwin, Trine Holt, et al.. (2019). Amyloid-β PET—Correlation with cerebrospinal fluid biomarkers and prediction of Alzheimer´s disease diagnosis in a memory clinic. PLoS ONE. 14(8). e0221365–e0221365. 33 indexed citations
16.
Strand, Bjørn Heine, Anne‐Brita Knapskog, Karin Persson, et al.. (2019). The Loss in Expectation of Life due to Early-Onset Mild Cognitive Impairment and Early-Onset Dementia in Norway. Dementia and Geriatric Cognitive Disorders. 47(4-6). 355–365. 10 indexed citations
17.
Chang, Linda, Andreas Engvig, Knut Jørgen Bjuland, et al.. (2019). Adaptive Computerized Working Memory Training in Patients With Mild Cognitive Impairment. A Randomized Double-Blind Active Controlled Trial. Frontiers in Psychology. 10. 807–807. 33 indexed citations
18.
Strand, Bjørn Heine, Anne‐Brita Knapskog, Karin Persson, et al.. (2018). Survival and years of life lost in various aetiologies of dementia, mild cognitive impairment (MCI) and subjective cognitive decline (SCD) in Norway. PLoS ONE. 13(9). e0204436–e0204436. 47 indexed citations
19.
Knapskog, Anne‐Brita, Rannveig Sakshaug Eldholm, Anne Brækhus, Knut Engedal, & Ingvild Saltvedt. (2017). Factors that influence the levels of cerebrospinal fluid biomarkers in memory clinic patients. BMC Geriatrics. 17(1). 210–210. 9 indexed citations
20.
Coutinho, Evandro Silva Freire, Cloyra Almeida, Maria Lage Barca, et al.. (2011). Validation of Montgomery-Åsberg Rating Scale and Cornell Scale for Depression in Dementia in Brazilian elderly patients. International Psychogeriatrics. 24(8). 1291–1298. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026